Press Releases

Washington, D.C. (February 14, 2017) – The European Commission announced today a proposal to revise its Comitology Regulation forcing policy decisions to individual EU member countries.

Long-time Majority Staff Director of the House Energy and Commerce Committee Dr. Gary Andres joins BIO as Senior Executive Vice President of Public Affairs.

BIO announced registration and housing are now open for the 2017 World Congress on Industrial Biotechnology.  The conference will be held July 23-26, 2017 at the Palais des congrès de Montréal in Montréal,…

Washington, DC (January 31, 2017) – BIO issued the following statement regarding President Trump’s comments today supporting biopharmaceutical innovation:

The U.S. Department of Agriculture (USDA) and the U.S. Food and Drug Administration (FDA) published today four documents related to the pre-market regulatory oversight of a variety of biology-based agricultural tools, including genetically…

Delivers Message: India Must Protects Innovators’ Work Product

BIO's statement  regarding proposed drug pricing legislation within the Maryland Senate.

BIO announced programming for the 19th annual BIO CEO & Investor Conference. Held February 13-14 at the Waldorf Astoria in New York, the annual conference provides an environment for investors, analysts, industry executives and others to…

Washington, DC (December 7, 2016) – Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement today regarding passage of the 21st Century Cures Act by the U.S. Senate:

Washington, DC (November 30, 2016) – Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement today regarding passage of the 21st Century Cures Act by the U.S. House of Representatives: